Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM
- PMID: 19009235
- PMCID: PMC3022444
- DOI: 10.1007/s11060-008-9719-x
Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM
Abstract
Glioblastoma Multiforme (GBM) are heterogeneous lesions, both in terms of their appearance on anatomic images and their response to therapy. The goal of this study was to evaluate the prognostic value of parameters derived from physiological and metabolic images of these lesions. Fifty-six patients with GBM were scanned immediately before surgical resection using conventional anatomical MR imaging and, where possible, perfusion-weighted imaging, diffusion-weighted imaging, and proton MR spectroscopic imaging. The median survival time was 517 days, with 15 patients censored. Absolute anatomic lesion volumes were not associated with survival but patients for whom the combined volume of contrast enhancement and necrosis was a large percentage of the T2 hyperintense lesion had relatively poor survival. Other volumetric parameters linked with less favorable survival were the volume of the region with elevated choline to N-acetylaspartate index (CNI) and the volume within the T2 lesion that had apparent diffusion coefficient (ADC) less than 1.5 times that in white matter. Intensity parameters associated with survival were the maximum and the sum of levels of lactate and of lipid within the CNI lesion, as well as the magnitude of the 10th percentile of the normalized ADC within the contrast-enhancing lesion. Patients whose imaging parameters indicating that lesions with a relatively large percentage with breakdown of the blood brain barrier or necrosis, large regions with abnormal metabolism or areas with restricted diffusion have relatively poor survival. These parameters may provide useful information for predicting outcome and for the stratification of patients into high or low risk groups for clinical trials.
Figures








Similar articles
-
Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen.Neuro Oncol. 2017 Mar 1;19(3):430-439. doi: 10.1093/neuonc/now159. Neuro Oncol. 2017. PMID: 27576874 Free PMC article.
-
Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy.J Neurooncol. 2009 Jan;91(1):69-81. doi: 10.1007/s11060-008-9685-3. Epub 2008 Sep 23. J Neurooncol. 2009. PMID: 18810326 Free PMC article.
-
Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume.J Magn Reson Imaging. 2004 May;19(5):546-54. doi: 10.1002/jmri.20039. J Magn Reson Imaging. 2004. PMID: 15112303
-
Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.Radiology. 2017 Jul;284(1):180-190. doi: 10.1148/radiol.2017160150. Epub 2017 Feb 27. Radiology. 2017. PMID: 28240563
-
Diffusion-weighted MR of the brain: methodology and clinical application.Radiol Med. 2005 Mar;109(3):155-97. Radiol Med. 2005. PMID: 15775887 Review. English, Italian.
Cited by
-
Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen.Neuro Oncol. 2017 Mar 1;19(3):430-439. doi: 10.1093/neuonc/now159. Neuro Oncol. 2017. PMID: 27576874 Free PMC article.
-
Non-invasive metabolic imaging of brain tumours in the era of precision medicine.Nat Rev Clin Oncol. 2016 Dec;13(12):725-739. doi: 10.1038/nrclinonc.2016.108. Epub 2016 Jul 19. Nat Rev Clin Oncol. 2016. PMID: 27430748 Free PMC article. Review.
-
Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy.J Neurooncol. 2009 Jan;91(1):69-81. doi: 10.1007/s11060-008-9685-3. Epub 2008 Sep 23. J Neurooncol. 2009. PMID: 18810326 Free PMC article.
-
Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer?Diagn Interv Radiol. 2016 Jan-Feb;22(1):75-89. doi: 10.5152/dir.2015.15009. Diagn Interv Radiol. 2016. PMID: 26712681 Free PMC article.
-
Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab.J Neurooncol. 2014 Aug;119(1):149-58. doi: 10.1007/s11060-014-1464-8. Epub 2014 May 8. J Neurooncol. 2014. PMID: 24805151
References
-
- Oh J, Henry RG, Pirzkall A, Lu Y, Li X, Catalaa I, et al. Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging. 2004;19:546–554. doi: 10.1002/jmri.20039. - DOI - PubMed
-
- Salvati M, Cervoni L, Artico M, Caruso R, Gagliardi FM. Long-term survival in patients with supratentorial glioblastoma. J Neurooncol. 1998;36:61–64. doi: 10.1023/A:1017926603341. - DOI - PubMed
-
- Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys. 1993;26:239–244. - PubMed
-
- Kowalczuk A, Macdonald RL, Amidei C, Dohrmann G, 3rd, Erickson RK, Hekmatpanah J, et al. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery. 1997;41:1028–1036. (discussion 1036–1038) doi: 10.1097/00006123-199711000-00004. - DOI - PubMed
-
- Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, De Monte F, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95:190–198. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical